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Available online 8 August 2016Patients with type 2 diabetes mellitus (T2DM) experience a 1.5–3.5 fold increase in fracture risk, but the mech-
anisms responsible for these alterations in bone biomechanical properties remain elusive.Macroautophagy, often
referred to as autophagy, is regulated by signaling downstream of the insulin receptor. Metabolic changes asso-
ciatedwith the progression of glucose intolerance have been shown to alter autophagy in various tissues, but lim-
ited information is available in relation to bone cells. The aim of this study was to (a) investigate whether
autophagy is altered in bone tissue during impaired glucose tolerance, and (b) determine how autophagy im-
pacts osteoblast differentiation, activity, and maturation. Four-week-old, male C57BL/6 mice were fed a control
(Con) or high fat (HF) diet for 2, 8, or 16 wks. Mice on the HF diet demonstrated elevated fasting blood glucose
and impaired glucose tolerance. Reduced trabecular bone in the femoral neck was evident in the mice on the HF
diet by 8wks compared to Conmice. Histological evaluation of the tibia suggested that the high fat diet promoted
terminal differentiation of the osteoblast to an osteocyte. This shift of the osteoblasts towards a non-mineralizing,
osteocyte phenotype appears to be coordinated by Beclin1-mediated autophagy. Consistent with these changes
in the osteoblast in vivo, the induction of autophagy was able to direct MC3T3-E1 cells towards a more mature
osteoblast phenotype. Although these data are somewhat observational, further investigation iswarranted to de-
termine if Beclin1-mediated autophagy is essential for the terminal differentiation of the osteoblasts andwhether
autophagy is having a protective or deleterious effect on bone in T2DM.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Osteocyte1. Introduction
Type 2 diabetes mellitus (T2DM) is amajor public health problem in
theU.S. affecting ~25million adults (Centers for Disease Prevention and
Control, 2011). The CDC has projected that the prevalence of T2DMwill
double or even triple, affecting 1 in 3 adults, by 2050 if current trends
continue (Centers for Disease Prevention and Control, 2011). In addition
to classic complications associatedwith T2DM, (e.g., peripheral vascular
disease, retinopathy, nephropathy, impaired wound healing, and neu-
ropathy) it has recently been established that type 2 diabetics are alsodvanced glycation end products;
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rotein; Ambra1, vacuole sorting
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. This is an open access article underat greater risk of fracture, primarily hip fracture, 5–10years post diagno-
sis. Furthermore, it was demonstrated that the clinical determinant of
fracture risk, bone mineral density (BMD), and theWorld Health Orga-
nization Fracture Risk Algorithm (FRAX) underestimate fracture risk in
adults with T2DM (Schwartz et al., 2011). While impaired insulin sig-
naling, alterations in the inﬂammatory response, and the accumulation
of advanced glycation end products (AGEs) have been proposed to con-
tribute to this phenomenon, the mechanism through which the bone
metabolic changes are occurring has remained elusive (Ferron et al.,
2010; O'Rourke, 2009; Cottam et al., 2004; Smith et al., 2006;
McCarthy et al., 1997; Vashishth, 2007). Therefore, to begin to under-
stand why T2DM increases skeletal fragility, it is imperative that alter-
ations in bone metabolism be investigated with increasing duration of
hyperglycemia and glucose intolerance.
The hyperglycemia associated with T2DM is attributed, in part, to di-
minished insulin sensitivity and alterations in the downstream signaling
cascade. The resulting alterations in cellular processes have not been ex-
tensively investigated in bone cells. Autophagy is one such process that
is controlled by proteins downstream of the insulin receptor (IR) and is
involved in energy (i.e., glucose) sensing, effectively regulating cell surviv-
al or death by means of organelle recycling (Bursch et al., 2008). Thisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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activation of the initiation complex (ULK1/2, FIP200, and Atg101),
2) membrane nucleation involving Beclin1's association with Vps34/15,
Atg14L, Ambra1 or UVRAG, 3) phagophore formation by Atg12, Atg5,
and Atg16, 4) sequestration and autophagosome formation facilitated
by phosphatidylethanolamine (PE) conjugation of LC3 (LC3-II), 5) follow-
ed by degradation via autophagosome-lysosome fusion (Wirth et al.,
2013; Tanida et al., 2004; Chan, 2012). Although changes in autophagy
have been demonstrated in β-cells, hepatocytes, cardiac myocytes, and
adipocytes during diabetes, no published reports have examinedwhether
autophagy is altered in bone cells during the development of impaired in-
sulin sensitivity during impaired insulin sensitivity (Masini et al., 2009;
Jansen et al., 2012; Nunez et al., 2013; Ost et al., 2010; Liu et al., 2009).
Similar to other mesenchymal-derived cells (e.g., myocytes and adipo-
cytes), bone forming osteoblasts express the IR; therefore, during glucose
intolerance, osteoblasts may experience impaired insulin signaling,
resulting in the up-regulation of autophagy.
While signiﬁcant advances in the ﬁeld of autophagy as it relates to
bone have been made in the past 5 yrs., conﬂicting evidence exists on
how alterations in the autophagic process will impact osteoblast differ-
entiation, maturation, and activity. For example, Yang et al. (Yang et al.,
2013) described a serum-deprivation model of autophagy utilizing
osteoblast-like MC3T3-E1 cells in which growth factors and insulin are
absent from the culture and noted increased initiation of autophagy
and autophagosome formation as evidenced by increased ULK1, Beclin1,
and LC3-II protein expression. Interestingly, when osteoblasts were
treatedwith estradiol, apoptotic eventswere decreasedwhile autophagy
was enhanced (Yang et al., 2013). In this case, autophagy induction by
estradiol was associated with a cytoprotective process; however, publi-
cations on glucocorticoid treatment and the free fatty acid, palmitate, de-
scribe autophagy as a means by which osteoblasts and osteocytes
undergo cell death (Gunaratnam et al., 2013; Xia et al., 2010). Two
ground-breaking studies related to autophagy and bone have utilized
conditional knockout models. Onal et al. (Onal et al., 2013) knocked-
out the autophagic protein, Atg7, in terminally differentiated osteocytes
(DMP1-Cre). These animals exhibited a decrease in femoral, spinal, and
total BMD,whichwas attributed to a decrease in both trabecular and cor-
tical bone. Further insight into how autophagy impacts bonemetabolism
was provided in an osteoblast (Osx-Cre) conditional knockout of FIP200,
in which the animals demonstrated dramatically lower trabecular and
cortical bone at 1, 2, and 6 months of age due to decreased bone forma-
tion (Liu et al., 2013). This study also provided evidence that autophagy
is up-regulated during osteoblast maturation and terminal differentia-
tion. Together, these two studies demonstrate that basal autophagy pro-
motes osteocyte function, supports nodule formation by osteoblasts and
contributes to the terminal differentiation of osteoblasts. Given our re-
cent report that the attenuation of bone formation associated with in-
creasing duration of impaired insulin signaling is primarily attributed
to suppressed osteogenesis (Rendina-Ruedy et al., 2015a), alterations
in autophagy of the osteoblast my contribute to this skeletal phenotype.
Based on the regulation of autophagy by the insulin signaling path-
way, insulin resistance during T2DMmay increase autophagy in osteo-
blasts initially providing protection from cellular stress and, possibly,
inducing cellular maturation. While limited literature exists to suggest
that autophagy is an important cellular process for osteoblast differenti-
ation and function, no studies have sought to determine howalterations
in insulin sensitivity and/or glucose availability in a model of T2DM
could impact these cells and the resulting skeletal phenotype. Previous
studies in other tissues/cells have also supported the notion that au-
tophagy may act in a biphasic manner, initially protecting cells from
stress occurring during reduced insulin sensitivity, while prolonged au-
tophagy could be detrimental (Liu et al., 2013; Eisenberg-Lerner et al.,
2009). Therefore, this studywas designed to (a) investigatewhether au-
tophagy is altered in the bone during the initial development and pro-
gression of glucose intolerance; and (b) determine how autophagy
impacts osteoblast differentiation, activity, and maturation.2. Materials and methods
2.1. Animal use and care
Four week old male C57BL/6N mice (Charles Rivers, Wilmington,
MA), referred to hereafter as C57BL/6, were utilized for the current
study. The rationale for choosing this mouse strain was based on their
metabolic and skeletal response to high fat diet, which was more similar
to clinical pathophysiology of T2DM versus the C57BL/6J strain
(Rendina-Ruedy et al., 2015a). The mice were allowed to acclimate for
1 wk. and then assigned to one of six groups (n= 8–10 mice/group) to
receive the control (Con; modiﬁed AIN-93M, sucrose matched, 10%
kcals from fat; Research Diets D12450J) or a high fat (HF; 60% kcals
from fat; Research Diets D12492) diet for 2, 8, or 16 wk. Bodyweight
and food intake were recorded throughout the study. At each study
end point, mice were anesthetized (ketamine/xylazine cocktail 70 and
30 mg/kg body weight, respectively) and exsanguinated via the carotid
artery. Plasma was collected by centrifuging whole blood in EDTA-
coated tubes for 15 min at 3000 ×g. Tibiae and femurs were
disarticulated and stripped of surrounding soft tissue. The femurs to be
used for microCT were stored in phosphate buffered saline (PBS) at
−4 °C, while femurs used for RNA and protein extraction were ﬂushed
of their bone marrow and stored in a cryotank (−140 °C). The tibiae
were stored in 10% neutral buffered formalin (NBF) until histological
processing. All procedures were approved by the Institutional Animal
Care and Use Committee of Oklahoma State University.
2.2. Intraperitoneal glucose tolerance test and plasma insulin (IGTT)
Three to ﬁve days prior to the termination of each study period,
mice were fasted for 6 h and blood glucose was determined at base-
line. Mice then received an intraperitoneal injection of glucose solu-
tion (2 g glucose/kg body weight) and their blood glucose was
monitored at 15, 30, 60, 90, and 120 min. Plasma insulin was also de-
termined at each study end point (i.e., 2, 8 and 16 wks) using a com-
mercially available ELISA kit (Crystal Chem, Downers Grove, IL).
2.3. Determination of alterations in microarchitecture by microCT
Previously, we have reported that impaired trabecular bone acquisi-
tion occurs over time in the distal femur metaphysis (Rendina-Ruedy
et al., 2015b). In this study, micro-computerized tomography
(microCT40, SCANCO Medical, Switzerland) was performed to deter-
mine if the compromise in trabecular bone was evident in the proximal
femur. Therefore, trabecular bone within the femoral neck was deter-
mined by scanning each specimen at a resolution of 2048 × 2048 pixels,
pixels, followed by identifying an approximately 280 μmvolumeof inter-
est (VOI) beginning 30 μm distal to the femoral neck growth plate. Tra-
becular bone parameters evaluated included bone volume expressed as
a percentage of total volume (BV/TV), trabecular number (Tb.N.), trabec-
ular thickness (Tb.Th.), trabecular separation (Tb·Sp.) connectivity den-
sity (Conn.Dens.) and structural model index (SMI). All of the acquired
images for trabecular and cortical bone were analyzed at a threshold of
340, and a sigma and support of 1.2 and 2.0, respectively.
2.4. Quantiﬁcation of osteoblasts and osteocytes in the tibia
Fixed tibial sampleswere processed by exposure to sequential dehy-
dration steps with ethanol, cleared with toluene, and parafﬁn embed-
ded. Using a Leica RM2165 microtome (Wetzlar, Germany) tibial
sections were cut on a longitudinal axis (5 μm each) and then stained
with hematoxylin and eosin. Osteoblasts were identiﬁed as cuboidal
cells (N3 cells) lining the trabecular bone surface (125 μm distal to the
growth plate in the tibial metaphyseal region) and osteocytes were dis-
tinguished in the tibial cortex located in developed lacuna (Clarke,
2008; Florencio-Silva et al., 2015). Osteoblasts and osteocytes were
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mal) and the means were calculated for each animal. Additionally,
empty lacunae were counted in the tibial cortex from 30 ﬁelds (20×
magniﬁcation) and quantiﬁed similarly.
2.5. Cell culture experiments
Mouse pre-osteoblast MC3T3-E1 cells (Riken BioResource Center,
Ibaraki, Japan) were maintained in complete αMEM containing 10%
fetal bovine serum (FBS), 100 U/L penicillin G and 100 mg/L streptomy-
cin, and 2 mM L-glutamine at 37 °C in a humidiﬁed atmosphere of 5%
CO2. For osteoblast differentiation experiments, osteogenic medium con-
taining completeαMEMsupplementedwith 10mMβ-glycerophosphate
and 25 μg/mL ascorbic acid was used. Rapamycin was used for the induc-
tion of autophagy (Noda & Ohsumi, 1998; Sarbassov et al., 2005; Kim
et al., 2002) while baﬁlomycin A1 (BafA1) was used to prevent the lyso-
somal degradation of LC3-II (Yamamoto et al., 1998) (Cayman Chemical
Company, Ann Arbor, MI), and both were dissolved in DMSO purged
with N2 according to the manufacture's speciﬁcations.
Undifferentiated pre-osteoblastic MC3T3-E1 cells were plated
(1.0 × 106 cells/cm2) and allowed to adhere for 24 h in complete
αMEM (i.e., 0 day differentiation). Cells were then treated with 0 μM
(Con and DMSO) or 10 μM rapamycin for 24 h. Due to the lysosomal
degradation of LC3B-II protein 0 or 200 nM of BafA1 was added to cul-
tures 2 h prior to RNA and protein harvest (e.g., 22 h). To determine
changes induce by autophagy in a more mature osteoblast, osteogenic
medium was added to MC3T3-E1 cultures, and cells were allowed to
differentiate for 7 days. Following this differentiation period, cells
were treated with 0 or 10 μM rapamycin for 24 h, while BafA1 was
added 2 h before the RNA and protein was extracted.
2.6. RNA extraction and qPCR analyses
Total RNA was extracted from pulverized, ﬂushed femurs (Spex
6770 Freezer Mill, Metuchen, NJ) and MC3T3-E1 cells using TriZol
Reagent (Life Technology, Rockville, MD), following the manufac-
turers' protocol. RNA was quantiﬁed using a Nanodrop Spectropho-
tometer (Rockland, DE) while gel electrophoresis was carried out
to verify the quantity and quality of all RNA samples. cDNA was syn-
thesized using 2 μg of total RNA pre-treated with DNase I and sub-
jected to reverse-transcription (Superscript II, Invitrogen, Carlsbad,
CA). Each qPCR reaction was performed in duplicate or triplicate
using SYBR green chemistry (SABiosciences, Valencia, CA) on the Ap-
plied Biosystems 7900HT Fast Real-Time PCR System (Foster City,
CA). All qPCR results were evaluated by the comparative cycle num-
ber at threshold (CQ) method (User Manual #2, Applied Biosystems),
using peptidylprolyl isomerase B (Ppib) as the invariant control.
Primer sets for target genes can be found in Supplemental materials
(Supp Table 1).
2.7. Protein extraction and western blot analyses
Crude protein was prepared from femur tissues (i.e., bone mar-
row ﬂushed) and MC3T3-E1 cells. Both the pulverized femur and
MC3T3-E1 cells were lysed using RIPA buffer containing a protease/
phosphatase inhibitor cocktail (Cell Signaling Technologies, Dancers,
MA). Lysates were incubated on ice for 40 min, with vortexing and
sonication every 10 min. Samples were then centrifuged at
16,000 ×g for 15 min at 4 °C. Supernatant containing total protein
was then aliquoted and stored at−80 °C. Prior to western blot anal-
yses, protein concentration was determined by bicinchoninic acid
(BCA) assay. Immunoblots were probed with primary antibodies
targeted against Beclin1 (Novus Biologicals, Littleton, CO), pBeclin1
(EMD Millipore, Billerica, MA), β-Actin (Santa Cruz Biotechnology,
Dallas, TX), and LC3B and ROCK1 (Cell Signaling Technology,
Danvers, MA).2.8. Statistical analyses
Statistical analyses were accomplished using SAS Version 9.3 (SAS
Institute, NC). Comparisons were made between dietary treatment
groups across all time points using two-way ANOVA, followed by post
hoc analysis with Fischer's least square means separation test when F
values were signiﬁcant (P b 0.05), unless otherwise stated. Results
from the IGTT at each study endpoint (i.e., 2, 8, or 16wk)were analyzed
separately by performing student's paired t-test to determine differ-
ences between the Con and HF groups at a given time point following
glucose administration (i.e., 15, 30, 60, 90, 120 min). In vivo, femur
western blot data were analyzed using a Wilcoxon signed-rank test
due to lack of normality between Con and HF diet groups at a given
time point. For in vitro experiments comparisons were made at a
given time between treatment groups and therefore, one-way ANOVA
was performed followed by post hoc analysis with Fischer's least square
means separation test when F values were signiﬁcant (P b 0.05).
3. Results
3.1. Metabolic and skeletal changes occurring in response to a high fat diet
with time
Mice on the HF diet exhibited elevated fasting blood glucose at
the 2, 8, and 16 wk. time points (Fig. 1A). At the 2-wk. time point,
mice on the HF diet were hypoinsulinemic (Con = 206.4 pg/mL;
HF = 148.0 pg/mL; P-value = 0.0025). No difference in fasting plas-
ma insulin was evident between dietary treatment groups at 8 wk.
(Con = 248.9 pg/mL; HF = 257.3 pg/mL; P-value = 0.8342), but after
16 wk. the mice on the HF diet demonstrated elevated plasma insulin
(Con = 370.8 pg/mL; HF = 736.7 pg/mL; P-value = 0.0159). At 2 wk.
(Fig. 1B) and 8 wk. (Fig. 1C) mice on the HF diet were able to restore
blood glucose to some extent by the 120 min time point of the IGTT
which is associated with impaired glucose tolerance or pre-diabetes.
However, given the results of the IGTT at 16 wk., it was evident that
mice on the HF diet were unable to restore blood glucose by the IGTT
ﬁnal time point, despite elevated insulin (Fig. 1D). Therefore, mice at
the 2 and 8 wk. time point on the HF diet demonstrated metabolic
changes corresponding to pre-diabetes, while the metabolic response
was more advanced at the later 16 wk. time point (i.e., hyperglycemia,
hyperinsulinemia, and glucose intolerance).
Trabecular BV/TV in the femoral neck was unchanged after 2 wk. on
theHF diet compared to the Con; however, mice on the HFdiet for 8 and
16 wk. exhibited signiﬁcantly less trabecular bone compared to Con
mice (Table 1). Although peak trabecular bone mass was achieved in
the Con mice at the 8 wk. experimental time point (or 13-wk.- old
mice), it was evident that trabecular bone deposition did not continue
at a normal rate after 2 wk. on the HF diet (Supp Fig. 1). A similar
trendwas observed in Tb.Th., Conn.Dens., and SMI, indicative of a struc-
turallyweaker bone (Table 1). Cortical bone (i.e., cortical thickness)was
previously shown to be reduced by 7.4% at the femur mid-diaphysis
(Rendina-Ruedy et al., 2015b).
Interestingly, histological evaluation of the proximal tibia
metaphysis in the 2 wk. Con group contained a large number of
cuboidal-shaped, active osteoblasts (Clarke, 2008; Florencio-Silva
et al., 2015), whereas the mice on the HF diet exhibited a dramatic
decrease in osteoblasts (Fig. 2A and B). To be expected, osteoblast
number decreased with age (e.g., 7, 13, and 21 wk. of age) in the
Con mice; however, the lowest number of osteoblasts was observed
in themice on a HF diet for 8 and 16 wk. (Fig. 2B). While these results
were somewhat expected given the decrease in trabecular bone vol-
ume, the animals on the HF diet had a higher number of osteocytes at
2, 8, and 16 wk., compared to their respective controls (Fig. 2C).
Taken together, these data suggest that the HF diet accelerated oste-
oblast terminal differentiation to an osteocyte. Although artifacts can
be problematic when performing histomorphometry on parafﬁn
Fig. 1. Fasting (6 h) blood glucose (A) was determined prior to the administration of the
intraperitoneal glucose tolerance test (IGTT). IGTT was performed by injecting (IP)
glucose solution (2 g glucose/kg bodyweight) and tracking blood glucose in mice that
were maintained on a control (Con; AIN93M) or high fat (HF; 60% kcal from fat) for 2
(B), 8 (C), and 16 (D) wk. Data are presented as the mean ± SE. Changes in fasting
blood glucose were determined by 2-way ANOVA to compare Con vs. HF at each study
endpoint while student's paired t-test was used to determine differences between the
Con and HF groups at a given time point following glucose administration (i.e., 15, 30,
60, 90, 120min). Bars that share the same superscript letter are not signiﬁcantly different
from each other (P b 0.05),while the symbol * represents a signiﬁcant difference (P b 0.05)
between dietary treatments at a given time point during the IGTT (Student's paired t-test).
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the cortex of mice on the HF diet at 2 and 8 wk., and these changes
were more pronounced at the 16 wk. time point (Fig. 2D).3.2. Determination of altered autophagy in bone during HF diet
To test the hypothesis that autophagy is up-regulated during HF
diet-induced metabolic derangements and contributing to the in-
duction of osteoblast maturation, proteins involved in autophagy
regulation were quantiﬁed in the femur (Fig. 3A). Interestingly, the
autophagy-speciﬁc post-translational modiﬁcation of Beclin1,
pBeclin1 (Thr119), protein abundance was shown to be the higher
in the 8 wk. HF group (Fig. 3A). No changes were observed in LC3B-
II protein abundance over time and in response to diet, but this was
predicted as LC3B-II was presumably degraded in the lysosome
(Fig. 3A). Although alterations were noted in pBeclin (Thr119), no
changes were observed in ROCK1, a kinase responsible for this site-
speciﬁc phosphorylation (Fig. 3A).
Gene expression analyses revealed that while no changes were ob-
served inMaplc3a (Fig. 3B) and Maplc3b (Fig. 3C), Becn1 (Fig. 3D) was
up-regulated after 2 wk. on HF diet, preceding the changes in pBeclin1
protein abundance. Furthermore, autophagy induction after 2 and
8wk. of HF diet appears to lower apoptosis given theCasp3mRNAabun-
dance, while apoptotic events appear to be elevated in the bone due to
prolonged HF diet feeding (Fig. 3E).
3.3. In vitro model of autophagy induction and transcriptional regulation of
osteoblastogenesis
To determine how the up-regulation of autophagy with glucose in-
tolerance affects osteoblastogenesis, MC3T3-E1 cells were cultured
with 10 μM rapamycin with the addition of 200 nM BafA1 for the last
2 h of the experiment to inhibit lysosomal degradation. Although it ap-
pears that immature (Fig. 4A) and mature osteoblasts (Fig. 4B) have
high levels of basal autophagy based on the abundance of LC3B-II in con-
trol cells (i.e., Con and DMSO-vehicle control), the addition of 10 μM
rapamycin for 24 h was able to increase autophagy as evidenced by in-
creased levels of LC3-II protein (Fig. 4C) and Maplc3a (Fig. 4D) and
Maplc3b (Fig. 4E) mRNA. However, no changes were observed in
Becn1mRNA or protein abundance of pBeclin1 or Beclin1 in undifferen-
tiated (0 d) or differentiated (7 d) MC3T3-E1 cells (data not shown).
With this model of autophagy induction in the osteoblast was
established, genes involved in osteoblast differentiation, activity, and
maturationwere determined. Immature, osteoblast MC3T3-E1 cells un-
dergoing autophagy induced via rapamycin treatment demonstrated
decreased levels of mRNA for genes critical for osteoblast differentiation
and early osteoblast activity including Atf4 (Fig. 5D), Cbfa1 (Fig. 5E), Alpl
(Fig. 5F), and Col1a (Fig. 5G). Conversely, an up-regulation was noted in
the cell cycle regulator Ccnd1 (Fig. 5A) and the gene that encodes osteo-
pontin, Spp1, an indicator of late osteoblast activity (Fig. 5H). While a
similar pattern was observed when autophagy was up-regulated in a
more mature osteoblasts (i.e., 7 day differentiation), Ccnd1mRNA (Fig.
5A) was lower in the rapamycin- treated group compared to controls
(Con and DMSO) and no changes were observed in Cbfa (Fig. 5E), Alpl
(Fig. 5F) and Col1a1 (Fig. 5G). In thesemoremature osteoblasts, a signif-
icant increase in osteocalcin gene expression (Bglap) was also noted
(Fig. 4). The differences in the regulation of these genes are presumably
indicative of the difference in transcriptional machinery essential dur-
ing the different stages of osteoblastogenesis. However, in both the un-
differentiated and differentiated MC3T3-E1 cells, enhanced autophagy
appears to drive the osteoblast towards a more mature phenotype.
4. Discussion
These data demonstrate that during the onset and progression of im-
paired glucose tolerance and diminished insulin sensitivity, trabecular
bone accrual is attenuated in the femoral neck, but to a lesser extent
than we have previously reported in the distal femur (Rendina-Ruedy
et al., 2015b). This phenotype is observed concurrently with alterations
in osteoblast maturation and up-regulated autophagy. These ﬁndings
Table 1
Alterations in trabecular microarchitecture of the femoral neck after 2, 8, and 16 wk.
2 Week 8 Week 16 Week P-value
Con HF Con HF Con HF Diet Time Diet ∗ time
BV/TV (%) 39.1 ± 1.8B 41.2 ± 3.4B 58.6 ± 3.7A 45.4 ± 3.0B 54.8 ± 2.7A 46.7 ± 1.7B 0.0077 0.0002 0.0323
Tb.N. (1/mm) 8.7 ± 0.2 8.8 ± 0.2 8.8 ± 0.3 8.4 ± 0.3 8.1 ± 0.2 7.6 ± 0.2 0.1576 0.0018 0.5284
Tb.Th. (μm) 56.3 ± 1.9E 60.2 ± 2.9DE 80.8 ± 4.9AB 66.5 ± 2.4CD 85.7 ± 4.6A 74.6 ± 1.8BC 0.013 b0.0001 0.0254
Tb. Sp. (μm) 101.5 ± 2.7 99.3 ± 4.9 89.7 ± 4.5 100.8 ± 7.0 102.1 ± 4.9 112.3 ± 3.1 0.1233 0.0500 0.3289
ConnDens (1/mm3) 453.3 ± 33.5 404.3 ± 21.2 253.6 ± 13.2 284.3 ± 24.4 179.2 ± 14.3 215.7 ± 8.7 0.7223 b0.0001 0.0834
SMI 0.56 ± 0.13A 0.41 ± 0.33AB −1.73 ± 0.36C −0.28 ± 0.23BD −1.10 ± 0.23C −0.44 ± 0.11D 0.0021 b0.0001 0.0105
MicroCT analyses of trabecular bone in the femoral neck at 2, 8, and 16 weeks on a control (Con= 10% kcal from fat) or HF (60% kcal from fat) diet. Trabecular parameters includes bone
volume/total volume (BV/TV), trabecular number (Tb.N.), thickness (Tb.Th.), and separation (Tb·Sp), aswell as connectivity density (ConnDens) and structuralmodel index (SMI). Values
are expressed as mean± SE. Data were analyzed using two-way ANOVA. Values within a given row that share the same superscript letter are not signiﬁcantly different from each
other (P b 0.05).
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osteoblasts towards a non-mineralizing cell, via a Beclin1-mediated
mechanism. While bone accrual was unchanged through the ﬁrst
2 wk., trabecular bone formation was diminished as impaired glucose
tolerance progressed. These microarchitectural changes from the femo-
ral neck are consistentwith our previous observations in thismodel that
bone formation was attenuated in the distal femoral metaphysis
(Rendina-Ruedy et al., 2015b). Although it has been shown by our lab
and others that hyperglycemia attenuates bone accrual due to de-
creased osteoblast differentiation (Rendina-Ruedy et al., 2015b; Lu
et al., 2013), the mechanisms involved and the fate of the osteoblasts
has not been fully explored. Histological evaluation of the proximal
tibia revealed that while osteoblast number and activitywas apparently
decreased during glucose intolerance, it appeared that osteocyteFig. 2.Representative images of hematoxylin and eosin (H&E) stained tibiae are shown (A) oste
control (Con; AIN93M) or high fat (HF; 60% kcal from fat) at the 2, 8, and 16wk. study endpoint
least square means separation test when F values were signiﬁcant (P b 0.05). Superscripts in
signiﬁcantly different from each other (P b 0.05).numbers were increased in these young animals. Although its lineage
is derived from an osteoblast, the primary role of the osteocyte is to
function as amechanosensing cell, and as such, is not suspected tomin-
eralize a substantial amount of bone (Lanyon, 1993; Bonewald, 2011).
While a more comprehensive evaluation of dynamic and static bone
histomorphometry is warranted, these data suggest that the apparent
increase in osteocyte number during the initiation of glucose intoler-
ance was driven by the up-regulation of osteoblast maturation, ulti-
mately, impairing bone formation.
The possible rationale for a scenario of increased autophagy contrib-
uting to osteoblastmaturation is two-fold. First, due to the control of au-
tophagy by proteins involved in insulin signaling and intracellular
energy sensors (e.g., mTORC1 and AMPK) this process could be altered
during varying degrees of insulin sensitivity/signaling (Masini et al.,oblast (B), osteocyte (C) numbers, and empty lacunae (D)were quantiﬁed from20ﬁelds in
s. The datawere analyzed by two-way ANOVA, followed by post hoc analysiswith Fischer's
dicate the diet ∗ time interaction and bars that share the same superscript letter are not
Fig. 3.Western blot analyses and qPCR was performed to determine changes in proteins and genes involved in autophagy from bone samples frommice fed a control (Con; AIN93M) or
high fat (HF; 60% kcal from fat) for 2, 8, and 16 wk. Representative images (n=5) of western blots probed for Beclin1, pBeclin1 (Thr119), LC3B, ROCK1 and β-Actin (A). Quantiﬁcation of
Beclin1 (B), pBeclin1 (C), LC3B-II (D), and ROCK1 (E) was carried out by determining density light units (DLU) for a given protein, and expressed normalized back to β-Actin (n=5). Due
to lack of normality, these datawere analyzed at a given time point using theWilcoxon rank test. Data are represented as averageDLU± standard error, and symbol * indicates signiﬁcance
(P b 0.05). qPCR results forMaplc3a (F),Maplc3b (G), Becn1 (H), and Casp3 (I) were normalized to peptidylprolyl isomerase B (Ppib) and expressed as relative mRNA abundance (n=6).
Datawere analyzed by two-way ANOVA, followed by post hoc analysiswith Fischer's least squaremeans separation testwhen F valueswere signiﬁcant (P b 0.05). All data are presented as
mean ± standard error (SE). Superscripts indicate the diet*time interaction and bars that share the same superscript letter are not signiﬁcantly different from each other (P b 0.05).
Fig. 4.An in vitromodel of increased autophagy in undifferentiated (0 d) and differentiated (7 d) osteoblastwas developed by subjectingMC3T3-E1 cells to treatmentwith 0 μM(Con and
DMSO) or 10 μM rapamycin for 24 h. 200 nM baﬁlomycin (BafA1) of was added to cultures 2 h prior (e.g., 22 h) to protein and RNA extraction. Representative images of western blot
analyses of LC3B-II abundance from undifferentiated (A) and differentiated (B) MC3T3-E1 cells are shown. LC3B-II protein abundance was determined by quantifying density light
units (DLU) normalized to γ-tubulin DLU (C). qPCR analysis ofMaplc3a (D) andMaplc3b (E), normalized to peptidylprolyl isomerase B (Ppib) and expressed as relativemRNA abundance.
Data is presented as the mean± SE (n=3). Data were analyzed by performing one-way ANOVA. followed by post hoc analysis with Fischer's least square means separation test when F
values were signiﬁcant (P b 0.05). Bars that share the same superscript letter are not signiﬁcantly different from each other (P b 0.05).
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Fig. 5. To determine how autophagy would impact osteoblast differentiation, activity and maturation undifferentiated (0 d) and differentiated (7 d), MC3T3-E1 cells were treated with
0 μM (Con and DMSO) or 10 μM rapamycin for 24 h. RNA was extracted and qPCR was performed to characterize alterations in genes of interest, including; Ccnd1 (A), Bmp2 (B), Bmp4
(C), Atf4 (D), Cbfa1 (E), Alpl (F), Col1a1 (G), Spp1 (H), and Bglap (I). All qPCR results were evaluated by the comparative cycle number at threshold (CQ) method, and genes of interest
were normalized to the invariant control, peptidylprolyl isomerase B (Ppib) and expressed as relative mRNA abundance. Data is presented as the mean ± SE (n = 6). Data were
analyzed using one-way ANOVA at a given time point (0 or 6 days) bars that share the same superscript letter are not signiﬁcantly different from each other (P b 0.05).
205E. Rendina-Ruedy et al. / Bone Reports 5 (2016) 199–2072009; Ost et al., 2010; Chen et al., 2011). Second, autophagy has been
suggested to be essential in the terminal differentiation of osteoblasts
to osteocytes (Liu et al., 2013; Nollet et al., 2014). While, one of the
most widely accepted indicators of autophagosome formation is LC3-II
protein abundance, a major limitation in using this method is that
LC3-II is readily degraded in the lysosome, making in vivo assessment
a challenge (Mizushima & Yoshimori, 2007). Due to these limitations,
Beclin1 protein expression was determined given its recently identiﬁedfunction as a key regulator of membrane nucleation and
autophagosome formation (Wirth et al., 2013). Beclin1 protein was
shown to be elevated in the femur following the more prolonged pe-
riods of glucose intolerance. Beclin1 has been demonstrated to regulate
autophagy by its existence in pro-autophagic complexes including
Barkor-Vps34-Vps15-Beclin1-AMBRA and Vps34-Vps15-Beclin1-Bif-1-
UVRAG, whereas Rubicon bound Vps34-Vps15-Beclin1-UVRAG com-
plex negatively functions in autophagosome maturation (Kang et al.,
206 E. Rendina-Ruedy et al. / Bone Reports 5 (2016) 199–2072011). Given the multi-functionality of Beclin1, elevated pBeclin1
(Thr119) was identiﬁed to be a speciﬁc indicator of autophagy activa-
tion in the ﬂushed femur of mice fed a HF diet for 8 wks. While the
stabilization of pBeclin1 at the 16 wk. time point was somewhat unex-
pected, given the autophagy-apoptosis axis (Eisenberg-Lerner et al.,
2009), these data could indicate that prolonged autophagy in these
cells has shifted the cellular response towards cell death bymeans of ap-
optosis. Active ROCK1 has been previously described to phosphorylate
Beclin1 at Thr119, up-regulating Beclin1-mediated autophagy by disso-
ciating the Beclin1-Bcl-xL complex (Gurkar et al., 2013). Moreover,
ROCK1 kinase activity has been shown to be altered during T2DM,mak-
ing it a suitable protein of interest in the currentmodel (Lee et al., 2014;
Lee et al., 2009). Although, no changes were observed in ROCK1 protein
abundance, ROCK1's activity was not assessed and may still provide an
explanation for the up-regulated Beclin1-mediated autophagy in this
model. Lastly, the fact that no changes were observed in LC3B-II protein
levels in the current study, in conjunctionwith the changes occurring in
Beclin1 and Maplc3a, Maplc3b, suggests an increase in autophagic ﬂux
or the degradation and turnover of sequestered cargo. Therefore, au-
tophagy appears to be increased in response to diminished insulin sen-
sitivity and/or hyperglycemia in osteoblasts and osteocytes; however, a
prolonged hyperglycemic state results in apoptosis of these cells.
The up-regulation of autophagy in osteoblast-like MC3T3-E1 cells
resulted in their maturation and terminal differentiation. This in vitro
model was able to conﬁrm some of the changes occurring in the
femur which was important because the bone tissue preparations
could still represent a heterogeneous cell population. Moreover, our
in vitro conclusions that autophagy induction enhances osteoblast dif-
ferentiation are further supported by Huang et al., who recently demon-
strated that rapamycin increased nodule formation by Alizarin staining
(Huang et al., 2015). While we attempted to enrich for osteoblast and
osteocyte cell populations by ﬂushing the bone marrow, these cells
are expected to be at different stages of differentiation, ranging from os-
teoblast progenitor cells, to terminally differentiated osteocytes. This
difference in cell populations from the femoral samples versus the iso-
lated MC3T3-E1 cells may account for some of the discrepancies in our
observations. For instance, the mechanism for autophagy induction in
impaired glucose tolerance in the bone appeared to involve a different
mechanism than rapamycin-induced autophagy in the MC3T3-E1
cells. Beclin1 mediated autophagy has previously been reported to be
a critical mechanism occurring with glucose deprivation in mouse em-
bryonic ﬁbroblasts (MEFs), and not essential for autophagy initiated
by rapamycin (Kim et al., 2013). Furthermore, the addition of BafA1 to
the MC3T3-E1 cell cultures allowed for the reliable visualization and
quantiﬁcation LC3B-II, however, no lysosomal inhibitor was used
in vivo. While these limitations could explain some of the differences
between the in vivo and in vitro data, both experimentalmodels provid-
ed consistent evidence that the up-regulation of autophagy shifts the
osteoblast towards a more mature phenotype.
This study is the ﬁrst to suggest that impaired insulin sensitivity and
hyperglycemia contribute to the dysregulation of bone metabolism by
up-regulating autophagy in osteoblasts, directing these cells towards
non-mineralizing osteocytes, and ultimately attenuating bone forma-
tion. Further investigation is warranted to determine if Beclin1-
mediated autophagy is essential for the terminal differentiation of the
osteoblasts and whether the promotion of autophagy during T2DM re-
sults in lower bone volume. Moreover, given the biphasic nature of au-
tophagy (i.e., cytoprotective vs. cell death), it may be possible that this
process exerts differentmechanisms on these bone cells resulting in dif-
ferent alterations in bone structure and/or biomechanics. While it is
speculated that altered autophagy occurs during glucose intolerance
as a result of impaired insulin signaling and/or intracellular glucose
availability, further studies are warranted to determine the precise
mechanism(s). Additionally, we also acknowledge that bone turnover
is a highly sophisticated, coupled process involving not only the osteo-
blasts and osteocytes, but also the osteoclasts which may also becontributing to the bone phenotype. However, due to the accelerated
rate of bone accrual occurring in these youngmice, we believe the alter-
ations occurring in the osteoblast outlined herein are of importance. The
novel concept that impaired bone formation can result from driving the
osteoblast towards a more mature, non-mineralizing phenotype em-
phasizes the need to better understand the fate and lifespan of osteo-
blasts, which could have signiﬁcant clinical implications.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bonr.2016.08.001.
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